2010•Journal of Medical ForumRequires access

Effect of MA Regimen in Treatment of Adult Acute Non-lymphocytic Leukemia

Qingzhu Hu

Open publisher page 0 citations

Abstract

Objective To evaluate mitoxantrone,cytarabine(MA) program for the induction treatment of adult acute non-lymphocytic leukemia(ANLL) patients with untreated patients.Methods Mitoxantrone an quinone(mitoxantrone) and cytosine arabinoside(cytarabine) in 35 cases of adult ANLL patients with chemotherapy.Results Clinical and hematological complete remission(CR) 15 cases(42.9%),partial remission(PR) 9 cases(25.7%),68.6% total efficiency.Conclusion On the basis of strong support for treatment,MA in the treatment of adults with refractory acute non-lymphocytic leukemia has a good effect,and its side effects can be tolerated.

About this research paper

What this paper is about

Objective To evaluate mitoxantrone,cytarabine(MA) program for the induction treatment of adult acute non-lymphocytic leukemia(ANLL) patients with untreated patients.Methods Mitoxantrone an quinone(mitoxantrone) and cytosine arabinoside(cytarabine) in 35 cases of adult ANLL patients with chemotherapy.Results Clinical and hematological complete remission(CR) 15 cases(42.9%),partial remission(PR) 9 cases(25.7%),68.6% total efficiency.Conclusion On the basis of strong support for treatment,MA in the treatment of adults with refractory acute non-lymphocytic leukemia has a good effect,and its side effects can be tolerated.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate mitoxantrone,cytarabine(MA) program for the induction treatment of adult acute non-lymphocytic leukemia(ANLL) patients with untreated patients.Methods Mitoxantrone an quinone(mitoxantrone) and cytosine arabinoside(cytarabine) in 35 cases of adult ANLL patients with chemotherapy.Results Clinical and hematological complete remission(CR) 15 cases(42.9%),partial remission(PR) 9 cases(25.7%),68.6% total efficiency.Conclusion On the basis of strong support for treatment,MA in the treatment of adults with refractory acute non-lymphocytic leukemia has a good effect,and its side effects can be tolerated.

Key concepts: Mitoxantrone, Cytarabine, Medicine, Refractory (planetary science), Leukemia, Chemotherapy, Internal medicine, Regimen

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of MA Regimen in Treatment of Adult Acute Non-lymphocytic Leukemia — Research Paper | ScholarLens